Casiopeina III-ia induces apoptosis in HCT-15 cells in vitro through caspase-dependent mechanisms and has antitumor effect in vivo

BioMetals

Volumn 21, Issue 1, 2008, Pages 17-28

  Carvallo Chaigneau, Francisco ^a   Trejo Solís, Cristina ^b   Gómez Ruiz, Celedonio ^a   Rodríguez Aguilera, Ernesto ^c   MacÍas Rosales, Lucía ^a   Cortés Barberena, Edith ^c   Cedillo Peláez, Carlos ^a   Gracia Mora, Isabel ^a   Ruiz Azuara, Lena ^a   Madrid Marina, Vicente ^d   Constantino Casas, Fernando ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c DEPARTAMENTO DE QUÍMICA   (Mexico)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Apoptosis; Bax; Casiopeina; Chemotherapy; p53( )

Indexed keywords

[(4,4' DIMETHYL 2,2 'BIPIRIDINE)(ACETYLACETONATE)CUPRIC NITRATE]; ANTINEOPLASTIC AGENT; CASIOPEINA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE INJURY; LIVER INJURY; MALE; MOUSE; NONHUMAN; SIDE EFFECT; WEIGHT GAIN;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BODY WEIGHT; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MICE; MICE, NUDE; ORGANOMETALLIC COMPOUNDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 38649143668     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-007-9089-4     Document Type: Article

References (41)

1. Brouns RE, Poot M, de Vrind R, Hoek-Kon T, Henderson PT, Kuyper CMA (1979) Measurement of DNA-excision repair suspensions of freshly isolated rat hepatocytes after exposure to some carcinogenic compounds. Its possible use in carcinogenic screening. Mut Res 64:425-432
2. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269-290
3. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler K, Vogelstein B (1999) Disruption of p53 in human cancer cells alters the response to therapeutic agents. J Clin Invest 104:263-269
4. Costanzo A, Merlo P, Pediconi N, Fulco M, Sartorelli V, Cole PA, Fontemaggi G, Fanciulli M, Schiltz L, Blandino G, Balsano C, Levero M (2002) DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol Cell 9:175-186
5. Cvitkovic E, Bekradda M (1999) Oxaliplatin: a new therapeutic option in colorectal cancer. Semin Oncol 26:647-662
6. De Vizcaya-Ruiz A, Rivero-Muller L, Ruiz-Ramírez L, Kass GEN, Kelland LR, Orr RM, Dobrota M (2000) Induction of apoptosis by a novel Copper-based anticancer compound, Casiopeina II, in L1210 murine Leukaemia and CH1 human ovarian carcinoma cells. Toxicol in vitro 14:1-5
7. di Zerega GS (1994) Contemporary adhesion prevention. Fertil Steril 61:219-235
8. Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ Jr, O'Connor PM (1995) Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 55:1649-1654
9. Fantin VR, Berardi MJ, Scorrano L, Kormeyer SJ, Leder P (2002) A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell 2:29-42
10. Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22:9030-9040
11. Gaiddon C, Jeannequin P, Bischoff P, Pfeffer M, Sirlin C, Loeffler JP (2005) Ruthenium (II)-derived organometallic compounds induces cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms. J Pharmacol Exp Ther 315:1403-1411
12. Gracia-Mora I, Ruiz-Ramírez L, Tinoco-Méndez M, Márquez-Quiñones A, Romero-De Lira M, Marín-Hernández A, Macías-Rosales M, Bravo-Gómez ME (2001) Knight́s move in the periodic table, from copper to platinum, novel antitumor mixed chelate copper compounds, casiopeinas, evaluated by an in vitro human and murine cancer cell line panel. Met Based Drug 8:19-28
13. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939-944
14. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC (2003) Chemosensitivity linked to p73 function. Cancer Cell 3:403-410
15. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153-164
16. Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256:42-49
17. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T (2003) Current status of the molecular mechanism of anticancer drug-induced apoptosis. The contribution of molecular-level analysis of chemotherapy. Cancer Chemother Pharmacol 50:343-352
18. Kothakota S, Azuma T, Reinard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT (1997) Caspase-3 generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278:294-298
19. Li P, Nijhawan D, Budihardjo I, Srinivasula S, Ahmad M, Alnemri E, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489
20. Liu X, Naekyung C, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147-157
21. ®) on mitochondrial functions. Biochem Pharmacol 65:1979-1989
22. Martin DA, Siegel RM, Zheng L, Lenardo M (1998) Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal. J Biol Chem 273:4345-4349
23. Mashima T, Naito M, Tsuruo T (1999) Caspase mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 18:2423-2430
24. Mashima T, Oh-hara T, Sato S, Mochizuki M, Sugimoto Y, Yamazaki K, Hamada J, Tada M, Moriuchi T, Ishikawa Y, Kato Y, Tomoda H, Yamori T, Tsuruo T (2005) p-53 defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target. J Natl Cancer Inst 97:765-777
25. Monk BJ, Berman NL, Montz FJ (1994) Adhesions after extensive gynecologic surgery: clinical significance, etiology, and prevention. Am J Obstet Gynecol 170:1396-1403
26. Muzio M, Salvesen G, Dixit V (1997) FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J Biol Chem 272:2952-2956
27. Muzio M, Stockwell B, Stennicke HR, Salvesen GS, Dixit V (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273:2926-2930
28. Nagata S (1997) Apoptosis by death factor. Cell 81:505-512
29. Ramadan S, Terrinoni A, Catani MV, Sayan E, Knight RA, Mueller M, Krammer PH, Melino G, Candi E (2005) p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun 331:713-717
30. Ruiz-Azuara L (1993) US Patent, Ap. 21 (1992), no. 5,107,005; US Patent, Re 35,458, February 18 (1997); US Patent November 19 (1996), no. 5,576,326, 407543 SECOFI
31. Saunders M, Iveson T (2006) Management of advanced colorectal cancer: state of the art. Br J Cancer 95:131-138
32. Shackelford RE, Kaufmann WK, Paules RS (2000) Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28:1387-1404
33. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bockesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112
34. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1:949-957
35. Theodorakis P, Lomonosova E, Chinnadurai G (2002) Critical requirement of Bax for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res 62:3373-3376
36. Tovar-Tovar A, Ruiz-Ramirez L, Campero A, Romerosa A, Moreno-Esparza R, Rosales-Hoz MJ (2004) Structural and reactivity studies on 4,4′-dimethyl- 2,2′-bipyridine acetylacetonate copper(II) nitrate (Casiopeína III-ia) with methionine, by UV-visible and EPR techniques [Cu(4,4′- dimethyl, 2,2′-bypiridine)(acac)]ClO4. J Inorg Biochem 98:1045-1053
37. Trejo-Solís C, Palencia G, Zúñiga S, Rodríguez-Ropón A, Osorio-Rico L, Sánchez-Torres L, Gracia-Mora I, Márquez-Rosado L, Sánchez A, Moreno García ME, Cruz A, Bravo-Gómez ME, Ruiz-Ramírez L, Rodríguez- Enríquez S, Sotelo-Morales J (2005) Cas IIgly induces apoptosis in glioma C6 cells in vitro and in vivo through caspase-dependent and caspase-independent mechanism of apoptosis. Neoplasia 6:563-574
38. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods 184:39-51
39. 2/M arrest and apoptosis. Nat Med 2:72-79
40. Zhang J, Xu M (2001) Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Biol 12:84-89
41. Ziegler U, Gloscurth P (2004) Morphological features of cell death. News Physiol Sci 19:124-128